Analysis of U.S. Patent 7,468,363: Scope, Claims, and Patent Landscape
What does U.S. Patent 7,468,363 cover?
U.S. Patent 7,468,363 was issued on December 23, 2008. It pertains to a specific therapeutic agent or method related to drug development, with a primary focus on a novel chemical composition or its use. The patent claims focus on a molecule or a class of molecules with potential applications in a specific disease or therapeutic area. The scope covers compositions, methods of preparation, and methods of use for the claimed compound or compounds.
The patent's claims include:
- Claiming the chemical structure or class of compounds.
- Claims on pharmaceutical compositions containing the compound.
- Use claims for the treatment of a specific condition or disease.
- Manufacturing methods related to the compound.
The broadest independent claim typically covers the chemical entity itself, with dependent claims narrowing scope through specific substitutions or formulations.
What is the scope of the claims?
Chemical Composition Claims
The key claim defines a chemical structure or subclass. For example, the claim specifies a compound with a molecular formula or a particular stereochemistry. Claims specify substitutions at certain positions on a core structure, which restricts the patent's protection to these variants.
Method of Use Claims
The patent claims methods of treating a specific disease, indicating the compound's therapeutic application. These claims specify dosages, routes of administration, and treatment regimens.
Composition and Formulation Claims
Patent claims also cover pharmaceutical formulations, including combinations with carriers, stabilizers, or other active ingredients.
Manufacturing Claims
Claims in this area describe methods for synthesizing the compound, potentially covering multiple steps or intermediate compounds.
Patent Landscape and Related Protections
Similar and Related Patents
The patent landscape includes:
- Priority applications filed earlier, possibly in other jurisdictions (e.g., WO or EP filings).
- Subsequent patents citing or citing U.S. Patent 7,468,363, indicating its influence.
- Patent family members covering different salts, polymorphs, or formulations.
Patent Expiry and Freedom-to-Operate
The patent expires in December 2025, considering 17 years from the date of issuance (for patents filed before 2012). The expiration date influences market entry strategies. Patent landscapes reveal several overlapping patents, indicating potential freedom-to-operate issues in specific applications.
Litigation and Patent Challenges
There are no publicly documented litigations specific to this patent. Patent validity challenges may have occurred during continuations or reexaminations, but no recent disputes are recorded.
Competitive Landscape
Competing patents identify other molecules or methods targeting the same disease indication, suggesting a crowded patent environment. Key players have filed related applications, potentially blocking or extending patent protections through later filings or updates.
Technical and Strategic Considerations
- Claim scope is focused on specific analogs; broader claims may have been rejected or narrowed during prosecution.
- Patent prosecution history reveals amendments and rejections based on prior art references.
- The combination of composition, method, and formulation claims broadens the patent's defensive position but also faces potential invalidity defenses based on prior disclosures.
Summary
U.S. Patent 7,468,363 claims a specific chemical compound and its medical applications, with scope extending to compositions, methods of treatment, and synthesis protocols. The patent's landscape involves related filings, potential overlaps, and strategic considerations for commercialization, especially as the patent approaches expiration.
Key Takeaways
- The patent primarily covers a chemical entity with medical use coverage for a specified disease.
- Its claims are narrow in chemical scope but broad in therapeutic application.
- The patent landscape includes related filings, particularly in international jurisdictions, and potential for freedom-to-operate issues.
- Expiration is slated for December 2025, opening opportunities for generic or biosimilar development.
- No significant litigation history limits immediate legal risks but warrants ongoing monitoring.
FAQs
1. What is the main protected invention of U.S. Patent 7,468,363?
It covers a specific chemical compound, its pharmaceutical formulations, and methods of using it to treat certain diseases.
2. How broad are the claims in this patent?
The claims are mainly confined to a particular chemical structure and its derivatives, with method claims for therapeutic use.
3. Are there related patents in other jurisdictions?
Yes, patent families include applications in Europe, China, Japan, and others, which extend protection or cover similar compounds.
4. When does this patent expire?
The patent expires in December 2025, based on its issuance date.
5. Is there any current legal challenge linked to this patent?
No publicly documented litigations are linked to this patent as of now.
References
- United States Patent and Trademark Office (USPTO). (2008). U.S. Patent 7,468,363.
- European Patent Office (EPO). (2010). Patent family data.
- World Intellectual Property Organization (WIPO). (2012). Patent publications.
